Astrana Health (ASTH) | Financial Analysis & Statements
Astrana Health Inc. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
950.5M
Gross Profit
95.0M
10.00%
Operating Income
18.4M
1.94%
Net Income
6.6M
0.69%
EPS (Diluted)
$0.12
Balance Sheet Metrics
Total Assets
2.2B
Total Liabilities
1.7B
Shareholders Equity
558.3M
Debt to Equity
2.97
Cash Flow Metrics
Operating Cash Flow
3.7M
Free Cash Flow
-6.0M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Astrana Health Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 3.2B | 2.0B | 1.4B | 1.1B | 773.9M |
| Cost of Goods Sold | 2.8B | 1.8B | 1.2B | 944.7M | 596.1M |
| Gross Profit | 341.5M | 271.4M | 215.0M | 199.5M | 177.8M |
| Gross Margin % | 10.7% | 13.3% | 15.5% | 17.4% | 23.0% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 217.3M | 154.1M | 112.6M | 77.7M | 62.1M |
| Other Operating Expenses | - | - | - | -6.2M | -6.5M |
| Total Operating Expenses | 217.3M | 154.1M | 112.6M | 71.5M | 55.5M |
| Operating Income | 78.5M | 89.4M | 84.6M | 104.3M | 98.2M |
| Operating Margin % | 2.5% | 4.4% | 6.1% | 9.1% | 12.7% |
| Non-Operating Items | |||||
| Interest Income | 12.2M | 14.5M | 14.2M | 2.0M | 1.6M |
| Interest Expense | 49.9M | 33.1M | 16.1M | 7.9M | 5.4M |
| Other Non-Operating Income | -1.1M | 10.1M | 7.1M | -11.7M | -16.6M |
| Pre-tax Income | 39.6M | 80.8M | 89.8M | 86.6M | 77.7M |
| Income Tax | 15.5M | 30.9M | 32.0M | 40.9M | 31.7M |
| Effective Tax Rate % | 39.2% | 38.2% | 35.6% | 47.2% | 40.8% |
| Net Income | 24.1M | 49.9M | 57.8M | 45.7M | 46.1M |
| Net Margin % | 0.8% | 2.5% | 4.2% | 4.0% | 6.0% |
| Key Metrics | |||||
| EBITDA | 135.4M | 141.1M | 128.3M | 133.4M | 109.2M |
| EPS (Basic) | $0.46 | $0.91 | $1.30 | $1.09 | $1.69 |
| EPS (Diluted) | $0.46 | $0.90 | $1.29 | $1.08 | $1.63 |
| Basic Shares Outstanding | 49075727 | 47416484 | 46705385 | 44999083 | 43702959 |
| Diluted Shares Outstanding | 49075727 | 47416484 | 46705385 | 44999083 | 43702959 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Astrana Health Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 429.5M | 288.5M | 293.8M | 288.0M | 233.1M |
| Short-term Investments | - | 2.4M | 2.5M | 5.6M | 53.4M |
| Accounts Receivable | 374.5M | 225.7M | 76.8M | 49.6M | 10.6M |
| Inventory | - | - | - | - | - |
| Other Current Assets | 26.3M | 22.9M | 17.4M | 14.8M | 18.6M |
| Total Current Assets | 863.3M | 638.5M | 461.5M | 428.1M | 404.5M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 35.7M | 32.6M | 37.4M | 20.4M | 15.4M |
| Goodwill | 2.0B | 956.7M | 629.3M | 615.0M | 575.6M |
| Intangible Assets | 271.0M | 118.2M | 71.6M | 76.9M | 82.8M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 48.7M | 32.6M | 18.2M | 20.5M | 21.9M |
| Total Non-Current Assets | 1.4B | 716.4M | 471.9M | 538.1M | 462.9M |
| Total Assets | 2.2B | 1.4B | 933.4M | 966.2M | 867.4M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 44.8M | 15.2M | 9.1M | 10.5M | 5.5M |
| Short-term Debt | 55.7M | 15.3M | 24.8M | 4.8M | 3.9M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 360.2M | 235.3M | 125.6M | 81.3M | 55.8M |
| Total Current Liabilities | 615.3M | 365.6M | 218.7M | 148.6M | 114.7M |
| Non-Current Liabilities | |||||
| Long-term Debt | 1.0B | 456.6M | 296.3M | 224.6M | 197.1M |
| Deferred Tax Liabilities | 5.5M | 4.6M | 4.1M | 14.2M | 30.1M |
| Other Non-Current Liabilities | 17.1M | 14.0M | 3.6M | 20.3M | 14.8M |
| Total Non-Current Liabilities | 1.0B | 475.1M | 303.9M | 259.1M | 242.0M |
| Total Liabilities | 1.7B | 840.7M | 522.6M | 407.7M | 356.7M |
| Equity | |||||
| Common Stock | 49.0K | 48.0K | 47.0K | 47.0K | 45.0K |
| Retained Earnings | 308.4M | 286.3M | 243.1M | 182.4M | 137.2M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 558.3M | 514.2M | 410.8M | 558.5M | 510.6M |
| Key Metrics | |||||
| Total Debt | 1.1B | 471.8M | 321.0M | 229.4M | 201.0M |
| Working Capital | 248.0M | 272.9M | 242.8M | 279.5M | 289.7M |
Balance Sheet Composition
Astrana Health Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 24.1M | 49.9M | 57.8M | 45.7M | 46.1M |
| Depreciation & Amortization | 45.7M | 27.9M | 17.7M | 17.5M | 17.5M |
| Stock-Based Compensation | 38.6M | 34.5M | 22.0M | 16.1M | 6.7M |
| Working Capital Changes | -7.8M | -52.8M | -20.4M | -2.8M | -36.3M |
| Operating Cash Flow | 109.9M | 70.6M | 73.4M | 67.0M | 46.0M |
| Investing Activities | |||||
| Capital Expenditures | -10.1M | -8.0M | -28.5M | -22.9M | -19.2M |
| Acquisitions | -533.5M | -156.1M | -7.5M | -18.5M | -3.9M |
| Investment Purchases | - | -2.6M | -6.2M | -1.9M | -28.0M |
| Investment Sales | - | 124.0K | 491.0K | 31.7M | 67.6M |
| Investing Cash Flow | -539.0M | -192.4M | -65.5M | -7.5M | 16.5M |
| Financing Activities | |||||
| Share Repurchases | -15.4M | -937.0K | -10.2M | -9.2M | -5.7M |
| Dividends Paid | -7.9M | -4.0M | -62.1M | -14.0M | -31.1M |
| Debt Issuance | 1.1B | 171.9M | 284.5M | 3.6M | 180.6M |
| Debt Repayment | -495.3M | -19.2M | -205.4M | -4.4M | -238.5M |
| Financing Cash Flow | 569.3M | 134.1M | 1.9M | -28.7M | 123.2M |
| Free Cash Flow | 104.5M | 44.2M | 39.7M | 59.2M | 51.1M |
| Net Change in Cash | 140.2M | 12.4M | 9.8M | 30.8M | 185.8M |
Cash Flow Trend
Astrana Health Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
73.30
Forward P/E
10.50
Price to Book
2.12
Price to Sales
0.59
PEG Ratio
-0.41
Profitability Ratios
Profit Margin
0.71%
Operating Margin
1.85%
Return on Equity
4.49%
Return on Assets
3.43%
Financial Health
Current Ratio
1.40
Debt to Equity
193.10
Beta
0.77
Per Share Data
EPS (TTM)
$0.46
Book Value per Share
$15.94
Revenue per Share
$64.83
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| ASTH | 1.9B | 73.30 | 2.12 | 4.49% | 0.71% | 193.10 |
| HCA Healthcare | 106.0B | 16.86 | -38.44 | -244.82% | 8.97% | -17.57 |
| Tenet Healthcare | 16.5B | 12.17 | 3.88 | 27.02% | 6.60% | 160.79 |
| Pediatrix Medical | 1.9B | 11.88 | 2.16 | 20.28% | 8.64% | 73.29 |
| Surgery Partners | 1.9B | 2,956.00 | 1.09 | 2.76% | -2.35% | 114.51 |
| Addus HomeCare | 1.8B | 18.10 | 1.58 | 9.33% | 6.74% | 15.79 |
Financial data is updated regularly. All figures are in the company's reporting currency.






